Notoginsenoside R1 reduces ischemic injury in cells and rats through CKLF1-dependent metabolic effects
Notoginsenoside R1 reduced ischemic injury in PC12 cells and pMCAO rats by suppressing CKLF1-dependent metabolic reprogramming, but the findings remain ...
